Tag: Lung Cancer Surgery Market Share

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The market for lung cancer surgery equipment has been experiencing strong growth recently, driven by advances in technology and an increasing number of lung cancer cases worldwide. As medical procedures evolve and more specialized treatment centers emerge, this sector is set to expand further in the coming years. Here is a detailed overview of the market size, key growth factors, trends, major players, and regional dynamics shaping this industry.

Projected Growth and Market Size of the Lung Cancer Surgery Equipment Market

The lung cancer surgery equipment market has shown significant growth and is poised to continue this trajectory. It is expected to increase from $3.73 billion in 2025 to $3.98 billion in 2026, marking a compound annual growth rate (CAGR) of 6.7%. This historical growth phase was largely driven by the limited availability of advanced thoracic surgery equipment, continued reliance on traditional open surgeries, a rising incidence of lung cancer, expansion in the number of hospitals and surgical clinics, and widespread adoption of standard biopsy and imaging techniques. Looking ahead, the market is forecasted to reach $5.1 billion by 2030, growing at a CAGR of 6.4%. This surge is attributed to the development of robotic-assisted and minimally invasive surgical tools, the integration of AI-enabled imaging and monitoring systems, increased funding for research and academic institutions, growing use of enhanced recovery after surgery (ERAS) protocols, and the expansion of specialized lung cancer treatment centers. Key trends expected in this period include the rise of minimally invasive lung surgeries, greater demand for advanced diagnostic and imaging equipment, integration of patient monitoring with surgical devices, heightened focus on postoperative care, and the growth of robotic-assisted thoracic surgery.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24594&type=smp

Factors Contributing to Demand in the Lung Cancer Surgery Equipment Market

One of the primary drivers of growth in this market is the increasing prevalence of lung cancer globally. Lung cancer arises when abnormal cells multiply uncontrollably in the lungs, typically linked to smoking and harmful environmental exposures. Rising cases are connected to factors such as tobacco smoke, air pollution, occupational carcinogens, and an aging population. Lung cancer surgery equipment plays a vital role in diagnosing the disease, surgically removing cancerous tissue, and supporting postoperative care through precise surgical and monitoring technologies. For example, in February 2025, the Cancer Council of Australia reported that approximately 15,122 people were diagnosed with lung cancer in 2024, with the average age at diagnosis being 72. Lung cancer ranks as the fifth most common cancer in the country, with about one in 20 Australians expected to receive a diagnosis by age 85. These statistics highlight how the growing lung cancer burden is propelling demand for surgical equipment tailored to this disease.

Key Trends Shaping the Lung Cancer Surgery Equipment Industry

Leading companies in the lung cancer surgery equipment market are focusing on advancing technologies such as robotically assisted bronchoscopy. This technique improves the accuracy and safety of localizing tumors and performing biopsies, especially for hard-to-reach lung nodules, facilitating early and precise diagnosis. Robotically assisted bronchoscopy uses robotic technology to guide a flexible bronchoscope into the lungs with greater precision than manual methods. For instance, in March 2025, Johnson & Johnson announced that its MONARCH QUEST system, a sophisticated robotic bronchoscopy platform, received U.S. FDA 510(k) clearance. This system represents the latest version of the MONARCH Platform designed to enhance lung cancer diagnosis through minimally invasive procedures. It integrates with the GE HealthCare OEC 3D mobile CBCT Imaging System, enabling real-time intraprocedural 3D imaging that significantly improves the accuracy of targeting lung nodules in difficult locations.

Access The Complete Lung Cancer Surgery Equipment Market Report:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report

Detailed Product Types and Applications in the Lung Cancer Surgery Equipment Market

This market is categorized based on product type, surgery type, application, and end user. By product type, it includes surgical instruments, access devices, imaging equipment, electrosurgical devices, biopsy devices, and patient monitoring equipment. Surgical instruments cover tools such as scalpels, forceps, retractors, scissors, and sutures. Access devices include trocars, catheters, guidewires, and introducers. Imaging equipment comprises CT scanners, MRI machines, PET scanners, X-ray systems, and ultrasound devices. Electrosurgical devices feature generators, probes, electrodes, and smoke evacuation systems. Biopsy devices are divided into needle, core, vacuum-assisted, and endoscopic biopsy tools. Patient monitoring equipment encompasses pulse oximeters, ECG monitors, respiratory monitors, blood pressure monitors, and temperature monitors. Surgery types include lobectomy, pneumonectomy, wedge resection, video-assisted thoracoscopic surgery (VATS), and robotic-assisted surgery. Applications span diagnosis, treatment, and aftercare or rehabilitation. End users mainly consist of hospitals, surgical clinics, ambulatory surgical centers, and research and academic institutions.

Competitive Landscape of the Lung Cancer Surgery Equipment Market

The lung cancer surgery equipment industry features several prominent companies competing strategically to expand their market presence. Major players include Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, KARL STORZ GmbH & Co KG, Integra LifeSciences Corporation, Richard Wolf GmbH, Angiodynamics Inc, B Braun Melsungen AG, Sontec Instruments Inc, Novadaq Technologies Inc, Stryker Corporation, CONMED Corporation, Smith & Nephew plc, and Ambu A S. These companies are focusing on innovation, product development, and strategic partnerships to strengthen their foothold in this competitive market.

Regional Outlook and Market Expansion Drivers for Lung Cancer Surgery Equipment

In 2025, North America emerged as the largest regional market for lung cancer surgery equipment. However, the Asia-Pacific region is expected to witness the fastest growth during the forecast period. The report covers multiple regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of global market dynamics and regional growth opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Size Of The Lung Cancer Surgery Equipment Market Progress Through 2030?

The lung cancer surgery equipment market size has experienced strong growth in recent years. It is projected to expand from $3.73 billion in 2025 to $3.98 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. The growth during the historic period can be ascribed to factors such as the limited availability of advanced thoracic surgery equipment, a reliance on traditional open surgeries, the increasing prevalence of lung cancer, a rising number of hospital and surgical clinics, and the adoption of standard biopsy and imaging procedures.

The lung cancer surgery equipment market is projected for significant expansion over the coming years. This market is anticipated to reach $5.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. This projected growth is driven by several factors, including the advancement of robotic-assisted and minimally invasive surgical instruments, the incorporation of AI-powered imaging and monitoring technologies, increased funding for research and academic institutions, the wider implementation of Enhanced Recovery After Surgery (ERAS) guidelines, and the establishment of more specialized centers for lung cancer treatment. Key trends anticipated during this period involve the increasing popularity of minimally invasive lung procedures, a heightened need for sophisticated imaging and diagnostic tools, the integration of patient monitoring systems with surgical devices, a greater emphasis on postoperative rehabilitation and follow-up care, and the spread of robotic-assisted thoracic surgical techniques.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24594&type=smp

Which Major Factors Are Contributing To The Development Of The Lung Cancer Surgery Equipment Market?

The increasing incidence of lung cancer is anticipated to fuel expansion in the lung cancer surgery equipment market in the foreseeable future. This condition involves the unchecked proliferation of aberrant cells within the lungs, frequently linked to tobacco use or detrimental environmental factors. The uptick in lung cancer diagnoses is primarily attributable to elevated exposure to risk factors like tobacco smoke, atmospheric contaminants, and workplace carcinogens, alongside a demographic shift towards an older population. Tools for lung cancer surgery serve to identify the disease, excise malignant tissue, and aid in recovery after operations via accurate surgical procedures and continuous patient observation. As an illustration, in February 2025, the Cancer Council, an Australian non-profit body, reported that approximately 15,122 people were diagnosed with lung cancer in Australia during 2024, with the typical age at diagnosis being 72. In Australia, lung cancer stands as the fifth most frequently diagnosed malignancy, and roughly one in 20 Australians is projected to receive such a diagnosis by the age of 85. Consequently, the expanding occurrence of lung cancer is propelling the development of the lung cancer surgery equipment market.

How Are Different Segment Groups Identified Within The Lung Cancer Surgery Equipment Market?

The lung cancer surgery equipment market covered in this report is segmented –

1) By Product Type: Surgical Instruments, Access Devices, Imaging Equipment, Electrosurgical Devices, Biopsy Devices, Patient Monitoring Equipment

2) By Surgery Type: Lobectomy Surgery, Pneumonectomy Surgery, Wedge Resection, Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

3) By Application: Diagnosis, Treatment, Aftercare And Rehabilitation

4) By End User: Hospitals, Surgical Clinics, Ambulatory Surgical Centers, Research And Academic Institutes

Subsegments:

1) By Surgical Instruments: Scalpels, Forceps, Retractors, Scissors, Sutures

2) By Access Devices: Trocars, Catheters, Guidewires, Introducers

3) By Imaging Equipment: CT Scanners, MRI Machines, PET Scanners, X-Ray Systems, Ultrasound Devices

4) By Electrosurgical Devices: Electrosurgical Generators, Electrosurgical Probes, Electrosurgical Electrodes, Smoke Evacuation Systems

5) By Biopsy Devices: Needle Biopsy Devices, Core Biopsy Devices, Vacuum-Assisted Biopsy Devices, Endoscopic Biopsy Devices

6) By Patient Monitoring Equipment: Pulse Oximeters, ECG Monitors, Respiratory Monitors, Blood Pressure Monitors, Temperature Monitors

Which Trends Are Influencing The Direction Of The Lung Cancer Surgery Equipment Market?

Leading companies in the lung cancer surgery equipment market are concentrating on developing devices for robotically assisted bronchoscopy. This focus aims to boost the precision and safety of tumor localization and biopsy, enhance access to hard-to-reach lung nodules, and support the early and accurate diagnosis of lung cancer. Robotically assisted bronchoscopy is an advanced medical procedure that utilizes robotic technology to guide a bronchoscope, a thin, flexible tube, into the lungs with greater precision and control than traditional manual techniques. For instance, in March 2025, Johnson and Johnson, a US-based pharmaceutical company, announced that its MONARCH QUEST system, a sophisticated robotic-assisted bronchoscopy technology, had received U.S. FDA 510(k) clearance. This system marks the latest evolution of the MONARCH Platform, which is engineered to improve the diagnosis of lung cancer through minimally invasive procedures. The system interfaces with the GE HealthCare OEC 3D mobile CBCT Imaging System, facilitating real-time, intraprocedural 3D imaging. This integration significantly improves the precision of targeting lung nodules, especially those located in difficult-to-access areas of the lung.

Who Are The Major Companies Operating In The Lung Cancer Surgery Equipment Market?

Major companies operating in the lung cancer surgery equipment market are Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, KARL STORZ GmbH & Co KG, Integra LifeSciences Corporation, Richard Wolf GmbH, Angiodynamics Inc, B Braun Melsungen AG, Sontec Instruments Inc, Novadaq Technologies Inc, Stryker Corporation, CONMED Corporation, Smith & Nephew plc, Ambu A S

Access The Complete Lung Cancer Surgery Equipment Market Report:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report

Which Region Has The Strongest Presence In The Lung Cancer Surgery Equipment Market?

North America was the largest region in the lung cancer surgery equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Lung Cancer Surgery Equipment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report

Browse Through More Reports Similar to the Global Lung Cancer Surgery Equipment Market 2026, By The Business Research Company

Lung Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

Thoracic Surgery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/thoracic-surgery-devices-global-market-report

Surgical Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/surgical-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Lung Cancer Surgery Equipment Market In 2026, And How Will Its Value Evolve By 2030?

The lung cancer surgery equipment market size has experienced significant expansion in recent years. It is anticipated to increase from $3.73 billion in 2025 to $3.98 billion in 2026, at a compound annual growth rate (CAGR) of 6.7%. The market’s historical development can be linked to factors such as the limited availability of advanced thoracic surgery equipment, the reliance on traditional open surgeries, the increasing prevalence of lung cancer, a rising number of hospital and surgical clinics, and the adoption of standard biopsy and imaging procedures.

Significant expansion is anticipated for the lung cancer surgery equipment market over the coming years. Projections indicate its value will reach $5.1 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.4%. This projected increase is linked to several factors, including advancements in robotic-assisted and minimally invasive surgical instruments, the incorporation of AI-powered imaging and monitoring systems, increased funding in research and academic institutions, the wider acceptance of enhanced recovery after surgery (ERAS) guidelines, and the establishment of more specialized lung cancer treatment facilities. Key developments expected during this period involve a greater embrace of minimally invasive lung procedures, an escalating need for sophisticated imaging and diagnostic apparatus, the merging of patient monitoring technologies with surgical tools, an intensified emphasis on post-operative recovery and subsequent care, and the broadening application of robotic-assisted thoracic surgeries.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report

What Key Factors Are Shaping The Lung Cancer Surgery Equipment Market Landscape?

The escalating prevalence of lung cancer is anticipated to propel the expansion of the lung cancer surgery equipment market. This condition involves the unchecked proliferation of abnormal cells within the lungs, often stemming from smoking or detrimental environmental contact. The increase in lung cancer diagnoses is primarily attributed to heightened exposure to risk factors including tobacco smoke, air pollution, and occupational carcinogens, alongside an aging demographic. Such equipment serves to diagnose the disease, remove cancerous tissue, and assist in post-operative care by means of precise surgical procedures and patient surveillance. As an illustration, the Cancer Council, an Australia-based non-profit organization, reported in February 2025 that approximately 15,122 individuals were diagnosed with lung cancer in Australia during 2024, with the average age at diagnosis recorded as 72. In the country, lung cancer stands as the fifth most frequently diagnosed cancer, and it is estimated that one in 20 Australians will receive such a diagnosis by the age of 85. Consequently, the increasing prevalence of lung cancer is fueling the expansion of the lung cancer surgery equipment market.

How Is The Lung Cancer Surgery Equipment Market Organized By Segment Classification?

The lung cancer surgery equipment market covered in this report is segmented –

1) By Product Type: Surgical Instruments, Access Devices, Imaging Equipment, Electrosurgical Devices, Biopsy Devices, Patient Monitoring Equipment

2) By Surgery Type: Lobectomy Surgery, Pneumonectomy Surgery, Wedge Resection, Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

3) By Application: Diagnosis, Treatment, Aftercare And Rehabilitation

4) By End User: Hospitals, Surgical Clinics, Ambulatory Surgical Centers, Research And Academic Institutes

Subsegments:

1) By Surgical Instruments: Scalpels, Forceps, Retractors, Scissors, Sutures

2) By Access Devices: Trocars, Catheters, Guidewires, Introducers

3) By Imaging Equipment: CT Scanners, MRI Machines, PET Scanners, X-Ray Systems, Ultrasound Devices

4) By Electrosurgical Devices: Electrosurgical Generators, Electrosurgical Probes, Electrosurgical Electrodes, Smoke Evacuation Systems

5) By Biopsy Devices: Needle Biopsy Devices, Core Biopsy Devices, Vacuum-Assisted Biopsy Devices, Endoscopic Biopsy Devices

6) By Patient Monitoring Equipment: Pulse Oximeters, ECG Monitors, Respiratory Monitors, Blood Pressure Monitors, Temperature Monitors

What Market Trends Are Affecting The Lung Cancer Surgery Equipment Market?

Leading companies operating in the lung cancer surgery equipment market are directing their efforts toward creating devices for robotically assisted bronchoscopy. This initiative seeks to improve the precision and safety of tumor localization and biopsy, enhance access to hard-to-reach lung nodules, and aid in the early and accurate diagnosis of lung cancer. Robotically assisted bronchoscopy is an advanced medical procedure that employs robotic technology to guide a bronchoscope, a thin, flexible tube, into the lungs with greater exactness and oversight compared to conventional manual methods. For instance, in March 2025, Johnson and Johnson, a US-based pharmaceutical company, announced that its MONARCH QUEST system, an advanced robotic-assisted bronchoscopy technology, had been granted U.S. FDA 510(k) clearance. This system represents the newest iteration of the MONARCH Platform, which is designed to improve the diagnosis of lung cancer using minimally invasive procedures. The system connects with the GE HealthCare OEC 3D mobile CBCT Imaging System, enabling real-time, intraprocedural 3D imaging. This integration enhances the precision of targeting lung nodules, especially those located in hard-to-reach areas of the lung.

Who Are The Industry Participants Involved In The Lung Cancer Surgery Equipment Market?

Major companies operating in the lung cancer surgery equipment market are Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, KARL STORZ GmbH & Co KG, Integra LifeSciences Corporation, Richard Wolf GmbH, Angiodynamics Inc, B Braun Melsungen AG, Sontec Instruments Inc, Novadaq Technologies Inc, Stryker Corporation, CONMED Corporation, Smith & Nephew plc, Ambu A S

Get The Full Lung Cancer Surgery Equipment Market Report:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report

Which Region Is The Leading Market For The Lung Cancer Surgery Equipment Market?

North America was the largest region in the lung cancer surgery equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Lung Cancer Surgery Equipment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report

Browse Through More Reports Similar to the Global Lung Cancer Surgery Equipment Market 2026, By The Business Research Company

Lung Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

Thoracic Surgery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/thoracic-surgery-devices-global-market-report

Surgical Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/surgical-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Lung Cancer Surgery Equipment Market In 2026, And How Will Its Value Evolve By 2030?

The lung cancer surgery equipment market size has experienced significant expansion in recent years. It is anticipated to increase from $3.73 billion in 2025 to $3.98 billion in 2026, at a compound annual growth rate (CAGR) of 6.7%. The market’s historical development can be linked to factors such as the limited availability of advanced thoracic surgery equipment, the reliance on traditional open surgeries, the increasing prevalence of lung cancer, a rising number of hospital and surgical clinics, and the adoption of standard biopsy and imaging procedures.

Significant expansion is anticipated for the lung cancer surgery equipment market over the coming years. Projections indicate its value will reach $5.1 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.4%. This projected increase is linked to several factors, including advancements in robotic-assisted and minimally invasive surgical instruments, the incorporation of AI-powered imaging and monitoring systems, increased funding in research and academic institutions, the wider acceptance of enhanced recovery after surgery (ERAS) guidelines, and the establishment of more specialized lung cancer treatment facilities. Key developments expected during this period involve a greater embrace of minimally invasive lung procedures, an escalating need for sophisticated imaging and diagnostic apparatus, the merging of patient monitoring technologies with surgical tools, an intensified emphasis on post-operative recovery and subsequent care, and the broadening application of robotic-assisted thoracic surgeries.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report

What Key Factors Are Shaping The Lung Cancer Surgery Equipment Market Landscape?

The escalating prevalence of lung cancer is anticipated to propel the expansion of the lung cancer surgery equipment market. This condition involves the unchecked proliferation of abnormal cells within the lungs, often stemming from smoking or detrimental environmental contact. The increase in lung cancer diagnoses is primarily attributed to heightened exposure to risk factors including tobacco smoke, air pollution, and occupational carcinogens, alongside an aging demographic. Such equipment serves to diagnose the disease, remove cancerous tissue, and assist in post-operative care by means of precise surgical procedures and patient surveillance. As an illustration, the Cancer Council, an Australia-based non-profit organization, reported in February 2025 that approximately 15,122 individuals were diagnosed with lung cancer in Australia during 2024, with the average age at diagnosis recorded as 72. In the country, lung cancer stands as the fifth most frequently diagnosed cancer, and it is estimated that one in 20 Australians will receive such a diagnosis by the age of 85. Consequently, the increasing prevalence of lung cancer is fueling the expansion of the lung cancer surgery equipment market.

How Is The Lung Cancer Surgery Equipment Market Organized By Segment Classification?

The lung cancer surgery equipment market covered in this report is segmented –

1) By Product Type: Surgical Instruments, Access Devices, Imaging Equipment, Electrosurgical Devices, Biopsy Devices, Patient Monitoring Equipment

2) By Surgery Type: Lobectomy Surgery, Pneumonectomy Surgery, Wedge Resection, Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

3) By Application: Diagnosis, Treatment, Aftercare And Rehabilitation

4) By End User: Hospitals, Surgical Clinics, Ambulatory Surgical Centers, Research And Academic Institutes

Subsegments:

1) By Surgical Instruments: Scalpels, Forceps, Retractors, Scissors, Sutures

2) By Access Devices: Trocars, Catheters, Guidewires, Introducers

3) By Imaging Equipment: CT Scanners, MRI Machines, PET Scanners, X-Ray Systems, Ultrasound Devices

4) By Electrosurgical Devices: Electrosurgical Generators, Electrosurgical Probes, Electrosurgical Electrodes, Smoke Evacuation Systems

5) By Biopsy Devices: Needle Biopsy Devices, Core Biopsy Devices, Vacuum-Assisted Biopsy Devices, Endoscopic Biopsy Devices

6) By Patient Monitoring Equipment: Pulse Oximeters, ECG Monitors, Respiratory Monitors, Blood Pressure Monitors, Temperature Monitors

What Market Trends Are Affecting The Lung Cancer Surgery Equipment Market?

Leading companies operating in the lung cancer surgery equipment market are directing their efforts toward creating devices for robotically assisted bronchoscopy. This initiative seeks to improve the precision and safety of tumor localization and biopsy, enhance access to hard-to-reach lung nodules, and aid in the early and accurate diagnosis of lung cancer. Robotically assisted bronchoscopy is an advanced medical procedure that employs robotic technology to guide a bronchoscope, a thin, flexible tube, into the lungs with greater exactness and oversight compared to conventional manual methods. For instance, in March 2025, Johnson and Johnson, a US-based pharmaceutical company, announced that its MONARCH QUEST system, an advanced robotic-assisted bronchoscopy technology, had been granted U.S. FDA 510(k) clearance. This system represents the newest iteration of the MONARCH Platform, which is designed to improve the diagnosis of lung cancer using minimally invasive procedures. The system connects with the GE HealthCare OEC 3D mobile CBCT Imaging System, enabling real-time, intraprocedural 3D imaging. This integration enhances the precision of targeting lung nodules, especially those located in hard-to-reach areas of the lung.

Who Are The Industry Participants Involved In The Lung Cancer Surgery Equipment Market?

Major companies operating in the lung cancer surgery equipment market are Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, KARL STORZ GmbH & Co KG, Integra LifeSciences Corporation, Richard Wolf GmbH, Angiodynamics Inc, B Braun Melsungen AG, Sontec Instruments Inc, Novadaq Technologies Inc, Stryker Corporation, CONMED Corporation, Smith & Nephew plc, Ambu A S

Get The Full Lung Cancer Surgery Equipment Market Report:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report

Which Region Is The Leading Market For The Lung Cancer Surgery Equipment Market?

North America was the largest region in the lung cancer surgery equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Lung Cancer Surgery Equipment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report

Browse Through More Reports Similar to the Global Lung Cancer Surgery Equipment Market 2026, By The Business Research Company

Lung Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

Thoracic Surgery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/thoracic-surgery-devices-global-market-report

Surgical Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/surgical-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Lung Cancer Surgery Equipment Market In 2026, And How Will Its Value Evolve By 2030?

The lung cancer surgery equipment market size has experienced significant expansion in recent years. It is anticipated to increase from $3.73 billion in 2025 to $3.98 billion in 2026, at a compound annual growth rate (CAGR) of 6.7%. The market’s historical development can be linked to factors such as the limited availability of advanced thoracic surgery equipment, the reliance on traditional open surgeries, the increasing prevalence of lung cancer, a rising number of hospital and surgical clinics, and the adoption of standard biopsy and imaging procedures.

Significant expansion is anticipated for the lung cancer surgery equipment market over the coming years. Projections indicate its value will reach $5.1 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.4%. This projected increase is linked to several factors, including advancements in robotic-assisted and minimally invasive surgical instruments, the incorporation of AI-powered imaging and monitoring systems, increased funding in research and academic institutions, the wider acceptance of enhanced recovery after surgery (ERAS) guidelines, and the establishment of more specialized lung cancer treatment facilities. Key developments expected during this period involve a greater embrace of minimally invasive lung procedures, an escalating need for sophisticated imaging and diagnostic apparatus, the merging of patient monitoring technologies with surgical tools, an intensified emphasis on post-operative recovery and subsequent care, and the broadening application of robotic-assisted thoracic surgeries.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report

What Key Factors Are Shaping The Lung Cancer Surgery Equipment Market Landscape?

The escalating prevalence of lung cancer is anticipated to propel the expansion of the lung cancer surgery equipment market. This condition involves the unchecked proliferation of abnormal cells within the lungs, often stemming from smoking or detrimental environmental contact. The increase in lung cancer diagnoses is primarily attributed to heightened exposure to risk factors including tobacco smoke, air pollution, and occupational carcinogens, alongside an aging demographic. Such equipment serves to diagnose the disease, remove cancerous tissue, and assist in post-operative care by means of precise surgical procedures and patient surveillance. As an illustration, the Cancer Council, an Australia-based non-profit organization, reported in February 2025 that approximately 15,122 individuals were diagnosed with lung cancer in Australia during 2024, with the average age at diagnosis recorded as 72. In the country, lung cancer stands as the fifth most frequently diagnosed cancer, and it is estimated that one in 20 Australians will receive such a diagnosis by the age of 85. Consequently, the increasing prevalence of lung cancer is fueling the expansion of the lung cancer surgery equipment market.

How Is The Lung Cancer Surgery Equipment Market Organized By Segment Classification?

The lung cancer surgery equipment market covered in this report is segmented –

1) By Product Type: Surgical Instruments, Access Devices, Imaging Equipment, Electrosurgical Devices, Biopsy Devices, Patient Monitoring Equipment

2) By Surgery Type: Lobectomy Surgery, Pneumonectomy Surgery, Wedge Resection, Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

3) By Application: Diagnosis, Treatment, Aftercare And Rehabilitation

4) By End User: Hospitals, Surgical Clinics, Ambulatory Surgical Centers, Research And Academic Institutes

Subsegments:

1) By Surgical Instruments: Scalpels, Forceps, Retractors, Scissors, Sutures

2) By Access Devices: Trocars, Catheters, Guidewires, Introducers

3) By Imaging Equipment: CT Scanners, MRI Machines, PET Scanners, X-Ray Systems, Ultrasound Devices

4) By Electrosurgical Devices: Electrosurgical Generators, Electrosurgical Probes, Electrosurgical Electrodes, Smoke Evacuation Systems

5) By Biopsy Devices: Needle Biopsy Devices, Core Biopsy Devices, Vacuum-Assisted Biopsy Devices, Endoscopic Biopsy Devices

6) By Patient Monitoring Equipment: Pulse Oximeters, ECG Monitors, Respiratory Monitors, Blood Pressure Monitors, Temperature Monitors

What Market Trends Are Affecting The Lung Cancer Surgery Equipment Market?

Leading companies operating in the lung cancer surgery equipment market are directing their efforts toward creating devices for robotically assisted bronchoscopy. This initiative seeks to improve the precision and safety of tumor localization and biopsy, enhance access to hard-to-reach lung nodules, and aid in the early and accurate diagnosis of lung cancer. Robotically assisted bronchoscopy is an advanced medical procedure that employs robotic technology to guide a bronchoscope, a thin, flexible tube, into the lungs with greater exactness and oversight compared to conventional manual methods. For instance, in March 2025, Johnson and Johnson, a US-based pharmaceutical company, announced that its MONARCH QUEST system, an advanced robotic-assisted bronchoscopy technology, had been granted U.S. FDA 510(k) clearance. This system represents the newest iteration of the MONARCH Platform, which is designed to improve the diagnosis of lung cancer using minimally invasive procedures. The system connects with the GE HealthCare OEC 3D mobile CBCT Imaging System, enabling real-time, intraprocedural 3D imaging. This integration enhances the precision of targeting lung nodules, especially those located in hard-to-reach areas of the lung.

Who Are The Industry Participants Involved In The Lung Cancer Surgery Equipment Market?

Major companies operating in the lung cancer surgery equipment market are Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, KARL STORZ GmbH & Co KG, Integra LifeSciences Corporation, Richard Wolf GmbH, Angiodynamics Inc, B Braun Melsungen AG, Sontec Instruments Inc, Novadaq Technologies Inc, Stryker Corporation, CONMED Corporation, Smith & Nephew plc, Ambu A S

Get The Full Lung Cancer Surgery Equipment Market Report:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report

Which Region Is The Leading Market For The Lung Cancer Surgery Equipment Market?

North America was the largest region in the lung cancer surgery equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Lung Cancer Surgery Equipment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report

Browse Through More Reports Similar to the Global Lung Cancer Surgery Equipment Market 2026, By The Business Research Company

Lung Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

Thoracic Surgery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/thoracic-surgery-devices-global-market-report

Surgical Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/surgical-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model